This report confirmed that the therapeutic strategies aimed at inhibiting NLRP3 inflammasome-mediated fibrosis by utilizing exogenous H2S might serve as efficient targeted therapy in diabetes mellitus. The gene discussed is NLRP3; the disease is diabetes mellitus.